Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.04% Nasdaq Up0.33%

Gilead Sciences Inc. (GILD)

-NasdaqGS

52.27 Down 0.52(0.99%) 11:00AM EDT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 9,702,517   8,385,385   7,949,420  
Cost of Revenue2,471,363  2,124,410  1,869,876  
Gross Profit 7,231,154   6,260,975   6,079,544  
Operating Expenses
Research Development1,759,945  1,229,151  1,072,930  
Selling General and Administrative1,461,034  1,241,983  1,044,392  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 4,010,175   3,789,841   3,962,222  
Income from Continuing Operations
Total Other Income/Expenses Net(37,279)66,581  60,287  
Earnings Before Interest And Taxes3,972,896  3,856,422  4,022,509  
Interest Expense360,916  205,418  108,961  
Income Before Tax3,611,980  3,651,004  3,913,548  
Income Tax Expense1,038,381  861,945  1,023,799  
Minority Interest17,967  14,578  11,508  
Net Income From Continuing Ops2,591,566  2,803,637  2,901,257  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 2,591,566   2,803,637   2,901,257  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 2,591,566   2,803,637   2,901,257  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.